Objectives

This study examined the incidence and risk factors of preoperative deep vein thrombosis (DVT) in patients presenting to an outpatient setting with an isolated calcaneal fracture.

Design

Retrospective chart review.

Setting

All patients included in the study presented to the treating surgeon at a Level I trauma center with isolated calcaneal fractures as an outpatient between 2005 and 2013.

Methods

These patients were either referred from outside hospitals, had been evaluated in the emergency department initially and presented for definitive care, or presented initially to the outpatient clinic. Patients included were over the age of 18, had a preoperative duplex ultrasonography of bilateral lower extremities per the treating surgeon's protocol, and had at minimum 6 weeks follow-up. Patients were excluded if they were a polytrauma, had a documented hypercoagulable state, or were on baseline pharmacologic anticoagulation for another condition. All patients had a preoperative duplex ultrasound of both lower extremities to evaluate for DVT at least 7 days after injury.

Main outcome measure

Patients found to have a preoperative DVT were compared with those who did not have preoperative DVT for possible risk factors.

Results

One hundred fifty-nine patients qualified for our study and of these, 19 (12%) were found to have a DVT preoperatively, almost all of which were in distal veins. All risk factors, including age, sex, and body mass index were analyzed as continuous variables. Older age was found to be a risk factor for DVT (P = 0.009, Odds Ratio = 1.06, 95% CI, 1.01-1.11). All other predictor variables, including body mass index (P = 0.05) and sex (P = 0.08), were not statistically significant predictors in our sample.

Conclusions

The incidence of preoperative DVT found here is almost 2 times as high as any previously published examination of lower extremity injuries. Physicians should be aware of this increase so they may counsel patients about the risks of DVTs and the likelihood of any sequelae from developing a DVT that may affect a patient's recovery.

Level of evidence

Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

PURPOSE: To characterize the morphology of the infraspinatus (IS) tendon and evaluate the bony anatomy of the humeral head (HH) to determine if there is a correlation between HH measurements and the amount of available IS tendon. METHODS: The superior-inferior width as well as the medial-lateral (M-L) length of the inferior and superior portions of the IS tendon were measured in 15 human cadaveric shoulders. Three measurements were then obtained for each corresponding humeral head: (1) anterior to posterior (A-P) distance, (2) midcoronal humeral head distance (MCHH), and (3) M-L distance. Pearson correlation coefficients (R) of tendon measurements relative to HH measurements were determined. RESULTS: The mean ± SD HH measurements were 44.3 ± 3.3 mm for A-P, 49.3 ± 3.4 mm at the MCHH, and 52.2 ± 3.4 mm in the M-L plane. The mean M-L length of the superior portion of the IS tendon was significantly different from the inferior portion (42.4 vs 31.0 mm, P < .0001). The mean ± SD width of the IS tendon was 19.4 ± 3.0mm. There was a statistically significant correlation (R = 0.58) between the M-L length of the superior IS tendon relative to the M-L HH distance (P < .05) and the A-P HH distance (P < .05). CONCLUSIONS: The superior M-L IS tendon length was significantly greater than the inferior M-L length. The M-L HH and the AP HH distances were significantly correlated to the M-L length of the superior portion of the IS tendon. These relationships may provide an estimation of the length of available IS tendon to help guide the management of Hill-Sachs lesions (HSLs). CLINICAL RELEVANCE: Knowledge of the available IS length can help optimize the management of HSLs following anterior shoulder dislocation. If IS tendon M-L length is less than HSL M-L length, then remplissage may result in capsulomyodesis rather than tenodesis. Placement of the superior anchor in a position that is as superior as possible within the HSL defect will maximize the opportunity for IS tenodesis.

Objectives

Therapeutic virtual reality (VR) has emerged as an effective, drug-free tool for pain management, but there is a lack of randomized, controlled data evaluating its effectiveness in hospitalized patients. We sought to measure the impact of on-demand VR versus "health and wellness" television programming for pain in hospitalized patients.

Methods

We performed a prospective, randomized, comparative effectiveness trial in hospitalized patients with an average pain score of ≥3 out of 10 points. Patients in the experimental group received a library of 21 VR experiences administered using the Samsung Gear Oculus headset; control patients viewed specialized television programming to promote health and wellness. Clinical staff followed usual care; study interventions were not protocolized. The primary outcome was patient-reported pain using a numeric rating scale, as recorded by nursing staff during usual care. Pre- and post-intervention pain scores were compared immediately after initial treatment and after 48- and 72-hours.

Results

There were 120 subjects (61 VR; 59 control). The mean within-subject difference in immediate pre- and post-intervention pain scores was larger in the VR group (-1.72 points; SD 3.56) than in the control group (-0.46 points; SD 3.01); this difference was significant in favor of VR (P < .04). When limited to the subgroup of patients with severe baseline pain (≥7 points), the effect of VR was more pronounced vs. control (-3.04, SD 3.75 vs. -0.93, SD 2.16 points; P = .02). In regression analyses adjusting for pre-intervention pain, time, age, gender, and type of pain, VR yielded a .59 (P = .03) and .56 (P = .04) point incremental reduction in pain versus control during the 48- and 72-hour post-intervention periods, respectively.

Conclusions

VR significantly reduces pain versus an active control condition in hospitalized patients. VR is most effective for severe pain. Future trials should evaluate standardized order sets that interpose VR as an early non-drug option for analgesia.